MHRA authorises Vumerity for multiple sclerosis patients
Vumerity is a next-generation oral fumarate treatment for adults with relapsing-remitting multiple sclerosis
Read More
Author: Lucy Parsons
NICE recommends Inrebic for rare blood cancer
Eligible adult patients with primary or secondary myelofibrosis will now be able to access the treatment on the NHS
Read More
NICE approves first long-acting jab for HIV to replace daily pills
The announcement follows a positive decision from the SMC in October 2021
Read More
Under-18s with COVID-19 in UK advised to wait 12 weeks for vaccine dose
The UKHSA have said that deferring the vaccine dose could help to reduce even further the small risk of heart inflammation following vaccination
Read More
European Commission approves Nucala treatment in three diseases
This marks the first targeted treatment for eosinophilic granulomatosis with polyangiitis (EGPA)
Read More- MIT’s new MRI brain light-detecting technique could support brain cell studies
- PharmaTimes MSEA and NIEA awards are open for entry
- BBSRC invests £48m in Babraham Institute to advance lifelong health research
- NHS reduces long waits for cancer care and achieves faster ambulance responses
- MHRA’s AI Airlock to address challenges for regulating AI medical devices
